Arbutus Biopharma Corp (ABUS): Weighted Average Diluted Shares
191.60M
Year ended 2025-12-31
+8.3%
3-year compound annual growth
+20.4%
5-year compound annual growth
+15.5%
10-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 191.60M | +3.2% | 2026-03-23, From 2025-01-01 |
| 2024-12-31 | 185.61M | +11.8% | 2026-03-23, From 2024-01-01 |
| 2023-12-31 | 165.96M | +10.0% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | 150.94M | +42.1% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | 106.24M | +40.1% | 2023-03-02, From 2021-01-01 |
| 2020-12-31 | 75.84M | n/a | 2022-03-03, From 2020-01-01 |
| No annual figure between 2018-12-31 and 2020-12-31. | |||
| 2018-12-31 | 55.30M | +1.1% | 2019-03-07, From 2018-01-01 |
| 2017-12-31 | 54.72M | +3.1% | 2019-03-07, From 2017-01-01 |
| 2016-12-31 | 53.07M | +16.7% | 2018-03-16, From 2016-01-01 |
| 2015-12-31 | 45.46M | +110.4% | 2018-03-16, From 2015-01-01 |
| 2014-12-31 | 21.60M | +41.2% | 2017-03-22, From 2014-01-01 |
| 2013-12-31 | 15.30M | +6.9% | 2016-03-09, From 2013-01-01 |
| 2012-12-31 | 14.32M | +26.5% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | 11.32M | +9.5% | 2014-03-28, From 2011-01-01 |
| 2010-12-31 | 10.33M | n/a | 2013-03-27, From 2010-01-01 |